Read More Pharma Industry News Amylyx Pharmaceuticals resumes AMX0114 clinical trials for ALS after FDA clears path Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) has announced that the U.S. Food and Drug Administration (FDA) has lifted the… byPallavi MadhirajuJanuary 21, 2025